$1.14
0.0757.04%
Last update: Nov 6, 4:42 PM
ProKidney Corp (PROK) Stock Price, Quote, News & History
PROKNASDAQ
ProKidney shares are trading sharply higher Wednesday morning. The stock is gaining following a marked surge on Tuesday driven by positive clinical trial data...
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Other companies in ProKidney’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
ProKidney has a consensus price target of $6.43.
The stock price for ProKidney (NASDAQ: PROK) is $1.14 last updated November 6, 2026 at 4:42 PM EST.
There are no upcoming dividends for ProKidney.
ProKidney does not have any upcoming earnings scheduled.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its...
